Blindness Stocks List

Recent Signals

Date Stock Signal Type
2021-05-14 ALC Lower Bollinger Band Walk Weakness
2021-05-14 ALC NR7 Range Contraction
2021-05-14 EYES Calm After Storm Range Contraction
2021-05-14 FGEN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 FGEN 20 DMA Support Bullish
2021-05-14 GKOS 1,2,3 Retracement Bearish Bearish Swing Setup
2021-05-14 GKOS NR7 Range Contraction
2021-05-14 GKOS Calm After Storm Range Contraction
2021-05-14 GKOS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 GKOS Narrow Range Bar Range Contraction
2021-05-14 GRAY Stochastic Reached Oversold Weakness
2021-05-14 GRAY Lower Bollinger Band Walk Weakness
2021-05-14 GRAY New 52 Week Low Weakness
2021-05-14 GRAY Doji - Bullish? Reversal
2021-05-14 ISEE Pocket Pivot Bullish Swing Setup
2021-05-14 ISEE Crossed Above 20 DMA Bullish
2021-05-14 OCGN NR7 Range Contraction
2021-05-14 OCGN Crossed Above 50 DMA Bullish
2021-05-14 OCGN Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-14 OCGN Narrow Range Bar Range Contraction
2021-05-14 OCUP Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 OCUP Pocket Pivot Bullish Swing Setup
2021-05-14 OPT 20 DMA Resistance Bearish
2021-05-14 OPT Slingshot Bearish Bearish Swing Setup

Recent News for Blindness Stocks

Date Stock Title
May 17 ALIM Alimera Sciences Appoints David Dyer, M.D. as Chief Retina Specialist
May 16 FGEN FGEN ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against FibroGen, Inc. - Expanded Class Period
May 15 FGEN Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against FibroGen, Inc. - Expanded Class Period
May 15 OCGN Will Covaxin's Success Against COVID Variants Make Ocugen a Big Winner?
May 15 OCGN Ocugen or Vaxart: Which Will Take Investors Further?
May 15 FGEN SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in FibroGen, Inc. of Class Action Lawsuit and Upcoming Deadline – FGEN
May 15 FGEN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DOX, FGEN, GOEV, VRM INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
May 14 FGEN FibroGen Shareholder Alert
May 14 FGEN Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Against FibroGen, Inc. - Expanded Class Period
May 14 FGEN The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GOEV, FGEN and CS
May 14 FGEN FIBROGEN INVESTOR ALERT: June 11, 2021 Deadline for Seeking Appointment as Lead Plaintiff In Securities Class Action Lawsuit Filed Against FibroGen, Inc. (FGEN)
May 14 OCGN It Won’t Take Much for Vaxart Stock to Pop Once Again
May 14 FGEN INVESTOR ACTION ALERT: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
May 14 FGEN FIBROGEN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against FibroGen, Inc. - FGEN
May 13 FGEN Lawsuits Filed Against CYDY, ROOT and FGEN - Jakubowitz Law Pursues Shareholders Claims
May 13 OCUP 2 “Strong Buy” Penny Stocks That Could See Outsized Gains
May 13 FGEN SHAREHOLDER ACTION NOTICE: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc.
May 13 FGEN FGEN INVESTORS ACT NOW: Contact HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, to Recover Losses Due to Alleged Securities Fraud
May 13 EYES Company News for May 13, 2021
May 13 OCGN Can Ocugen Overcome This Major Hurdle?

Visual impairment, also known as vision impairment or vision loss, is a decreased ability to see to a degree that causes problems not fixable by usual means, such as glasses. Some also include those who have a decreased ability to see because they do not have access to glasses or contact lenses. Visual impairment is often defined as a best corrected visual acuity of worse than either 20/40 or 20/60. The term blindness is used for complete or nearly complete vision loss. Visual impairment may cause people difficulties with normal daily activities such as driving, reading, socializing, and walking.The most common causes of visual impairment globally are uncorrected refractive errors (43%), cataracts (33%), and glaucoma (2%). Refractive errors include near sighted, far sighted, presbyopia, and astigmatism. Cataracts are the most common cause of blindness. Other disorders that may cause visual problems include age related macular degeneration, diabetic retinopathy, corneal clouding, childhood blindness, and a number of infections. Visual impairment can also be caused by problems in the brain due to stroke, premature birth, or trauma among others. These cases are known as cortical visual impairment. Screening for vision problems in children may improve future vision and educational achievement. Screening adults without symptoms is of uncertain benefit. Diagnosis is by an eye exam.The World Health Organization (WHO) estimates that 80% of visual impairment is either preventable or curable with treatment. This includes cataracts, the infections river blindness and trachoma, glaucoma, diabetic retinopathy, uncorrected refractive errors, and some cases of childhood blindness. Many people with significant visual impairment benefit from vision rehabilitation, changes in their environment, and assistive devices.As of 2015 there were 940 million people with some degree of vision loss. 246 million had low vision and 39 million were blind. The majority of people with poor vision are in the developing world and are over the age of 50 years. Rates of visual impairment have decreased since the 1990s. Visual impairments have considerable economic costs both directly due to the cost of treatment and indirectly due to decreased ability to work.

More about Blindness
Browse All Tags